Patent US4083968A successfully refreshed from Google Patents.
US4083968A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Therapeutic agent for improving cardiovascular function
Assignee: F Hoffmann La Roche AG
•
Filing: 1976-01-09
•
Granted: 1978-04-11
•
Expires: 1996-01-09
Abstract
Abstract Methods of and compositions for improving cardiovascular function utilizing as the active agent certain pharmaceutically acceptable salts, derivatives, isomers and homologs of lasalocid (formerly known as antibiotic X-537A) are disclosed.
Inventors
- 👤 John Westley
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 11:47
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/35
Claims Analysis
Total Claims: 4
Claim 1
Independent Claim
35 words
A method for producing myocardial stimulation in a patient requiring such an effect which comprises parenterally administering to the patient an amount of the compound lasalocid, di-(N-methylglucamine) salt which is effective for producing myocardial stimulation.
Claim 2
Independent Claim
35 words
A method for producing myocardial stimulation in a patient requiring such an effect which comprises parenterally administering to the patient an amount of the compound lasalocid, di-(N-methylglucamine) salt which is effective for producing myocardial stimulation.
Claim 3
Dependent Claim
39 words
A pharmaceutical parenteral composition for producing myocardial stimulation in patients requiring such effects comprising an inert non-toxic pharmaceutically acceptable carrier base and, as the active ingredient an amount which is effective in producing myocardial stimulation of lasalocid, di-(N-methylglucamine) salt.
Claim 4
Dependent Claim
39 words
A pharmaceutical parenteral composition for producing myocardial stimulation in patients requiring such effects comprising an inert non-toxic pharmaceutically acceptable carrier base and, as the active ingredient an amount which is effective in producing myocardial stimulation of lasalocid, di-(N-methylglucamine) salt.
References Cited (Backward Citations)
US3715372A
Cited
US3873715A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1981-04-10 | 1981-10-10 | 1982-04-11 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1985-04-10 | 1985-10-10 | 1986-04-11 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1989-04-10 | 1989-10-10 | 1990-04-11 | $7700.00 | Window Closed / Lapsed |